Last reviewed · How we verify

NSAID (Aceclofenac)

Dong-A ST Co., Ltd. · FDA-approved active Small molecule

Aceclofenac inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain.

Aceclofenac inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain. Used for Rheumatoid arthritis, Osteoarthritis, Ankylosing spondylitis.

At a glance

Generic nameNSAID (Aceclofenac)
SponsorDong-A ST Co., Ltd.
Drug classNSAID (nonsteroidal anti-inflammatory drug)
TargetCOX-1, COX-2
ModalitySmall molecule
Therapeutic areaPain Management, Rheumatology, Inflammation
PhaseFDA-approved

Mechanism of action

As a nonsteroidal anti-inflammatory drug (NSAID), aceclofenac preferentially inhibits COX-2 while also affecting COX-1, suppressing the production of pro-inflammatory prostaglandins. This mechanism reduces pain, inflammation, and fever. Aceclofenac is a prodrug that is metabolized to diclofenac, which accounts for much of its pharmacological activity.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results